Home
Blogs

Podcast: The regulatory interplay between medical devices and medicines in clinical trials - EU and U.S. focus (Part 1)

Blog Post

22 September 2023

Authors

Sapna Palla

Partner

New York

Eda Zhuleku

Counsel

Munich

Rafi Allos

Partner

London

Browse this blog post

Related news and insights

Blog Post: 03 April 2024

European Commission opens unprecedented abuse of dominance probe in animal medicines sector

Blog Post: 28 March 2024

Czech Republic draws blood after English High Court finds serious irregularity in investment treaty arbitration award

Publications: 26 February 2024

Chief information Security Officers and cyber whistleblowing: considerations for boards and breach response teams

News: 09 February 2024

Allen & Overy advises Sartorius group on EUR1.4bn equity raising

The regulatory frameworks for medicines and medical devices have historically grown up on separate tracks, but increasingly, medicines and medical devices are being used together in patients as drug device combinations, companion diagnostics and medical devices used in clinical trials.

Join Sapna Palla, Eda Zhuleku and Rafi Allos in part one of this podcast series to discuss the use of medical devices in clinical trials and the different perspectives between the EU and U.S., as well as the regulatory requirements that may apply